These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Activation of GRP78 on endothelial cell membranes by an ADAM15-derived peptide induces angiogenesis. Raiter A; Weiss C; Bechor Z; Ben-Dor I; Battler A; Kaplan B; Hardy B J Vasc Res; 2010; 47(5):399-411. PubMed ID: 20145413 [TBL] [Abstract][Full Text] [Related]
4. Angiogenic peptides improve blood flow and promote capillary growth in a diabetic and ischaemic mouse model. Raiter A; Bechor Z; Kleiman M; Leshem-Lev D; Battler A; Hardy B Eur J Vasc Endovasc Surg; 2010 Sep; 40(3):381-8. PubMed ID: 20226697 [TBL] [Abstract][Full Text] [Related]
5. Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse. Bir SC; Esaki J; Marui A; Yamahara K; Tsubota H; Ikeda T; Sakata R J Vasc Surg; 2009 Oct; 50(4):870-879.e2. PubMed ID: 19679427 [TBL] [Abstract][Full Text] [Related]
6. Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia. Ruifrok WP; de Boer RA; Iwakura A; Silver M; Kusano K; Tio RA; Losordo DW Vasc Med; 2009 Feb; 14(1):29-36. PubMed ID: 19144777 [TBL] [Abstract][Full Text] [Related]
7. WKYMVm-induced activation of formyl peptide receptor 2 stimulates ischemic neovasculogenesis by promoting homing of endothelial colony-forming cells. Heo SC; Kwon YW; Jang IH; Jeong GO; Yoon JW; Kim CD; Kwon SM; Bae YS; Kim JH Stem Cells; 2014 Mar; 32(3):779-90. PubMed ID: 24155208 [TBL] [Abstract][Full Text] [Related]
8. Angiogenesis induced by novel peptides selected from a phage display library by screening human vascular endothelial cells under different physiological conditions. Hardy B; Raiter A; Weiss C; Kaplan B; Tenenbaum A; Battler A Peptides; 2007 Mar; 28(3):691-701. PubMed ID: 17187899 [TBL] [Abstract][Full Text] [Related]
9. Ursolic acid induces allograft inflammatory factor-1 expression via a nitric oxide-related mechanism and increases neovascularization. Lee AW; Chen TL; Shih CM; Huang CY; Tsao NW; Chang NC; Chen YH; Fong TH; Lin FY J Agric Food Chem; 2010 Dec; 58(24):12941-9. PubMed ID: 21070071 [TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-mediated endothelial cell-selective delivery of pitavastatin induces functional collateral arteries (therapeutic arteriogenesis) in a rabbit model of chronic hind limb ischemia. Oda S; Nagahama R; Nakano K; Matoba T; Kubo M; Sunagawa K; Tominaga R; Egashira K J Vasc Surg; 2010 Aug; 52(2):412-20. PubMed ID: 20573471 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic angiogenesis with intramuscular injection of low-dose recombinant granulocyte-colony stimulating factor. Lee M; Aoki M; Kondo T; Kobayashi K; Okumura K; Komori K; Murohara T Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2535-41. PubMed ID: 16224058 [TBL] [Abstract][Full Text] [Related]
12. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Cho SW; Moon SH; Lee SH; Kang SW; Kim J; Lim JM; Kim HS; Kim BS; Chung HM Circulation; 2007 Nov; 116(21):2409-19. PubMed ID: 17984381 [TBL] [Abstract][Full Text] [Related]
15. Angiopoietin-related growth factor enhances blood flow via activation of the ERK1/2-eNOS-NO pathway in a mouse hind-limb ischemia model. Urano T; Ito Y; Akao M; Sawa T; Miyata K; Tabata M; Morisada T; Hato T; Yano M; Kadomatsu T; Yasunaga K; Shibata R; Murohara T; Akaike T; Tanihara H; Suda T; Oike Y Arterioscler Thromb Vasc Biol; 2008 May; 28(5):827-34. PubMed ID: 18258819 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic neovascularization by nanotechnology-mediated cell-selective delivery of pitavastatin into the vascular endothelium. Kubo M; Egashira K; Inoue T; Koga J; Oda S; Chen L; Nakano K; Matoba T; Kawashima Y; Hara K; Tsujimoto H; Sueishi K; Tominaga R; Sunagawa K Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):796-801. PubMed ID: 19325146 [TBL] [Abstract][Full Text] [Related]
17. Call for a reference model of chronic hind limb ischemia to investigate therapeutic angiogenesis. Yang Z; von Ballmoos MW; Diehm N; Baumgartner I; Kalka C; Di Santo S Vascul Pharmacol; 2009 Oct; 51(4):268-74. PubMed ID: 19619670 [TBL] [Abstract][Full Text] [Related]
18. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia. Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433 [TBL] [Abstract][Full Text] [Related]
19. Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism. Schgoer W; Theurl M; Jeschke J; Beer AG; Albrecht K; Gander R; Rong S; Vasiljevic D; Egger M; Wolf AM; Frauscher S; Koller B; Tancevski I; Patsch JR; Schratzberger P; Piza-Katzer H; Ritsch A; Bahlmann FH; Fischer-Colbrie R; Wolf D; Kirchmair R Circ Res; 2009 Nov; 105(10):994-1002. PubMed ID: 19797703 [TBL] [Abstract][Full Text] [Related]
20. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia. Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]